Matthew Strobeck, Director at BIODESIX INC (BDSX), bought 147,800 shares at $4.35 ($643K) on 2021-12-30, disclosed to the SEC on 2022-01-04.
Open-market purchase of $643k BDSX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.35 | 9,100 | $40K | 6.2% |
| 2 | $4.35 | 138,700 | $603K | 93.8% |
| Total | $4.35 avg | 147,800 | $643K | 100% |
| Filing → |
| AZYO | BUY | 2023-02-13 | $398K | — | Filing → |
| BDSX | BUY | 2022-11-21 | $5.4M | — | Filing → |
| BDSX | BUY | 2022-04-11 | $2.0M | — | Filing → |